A. Franklin

发表

Starting an adolescent and young adult program: some success stories and some obstacles to overcome.

A. Ferrari, W. T. van der Graaf, B. Hayes-Lattin, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and clinical activity of 5‐aza‐2′‐deoxycytidine (decitabine) with or without Hyper‐CVAD in relapsed/refractory acute lymphocytic leukaemia

H. Kantarjian, G. Garcia-Manero, F. Ravandi, 2014, British journal of haematology.

If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical records.

J. Pow-Sang, Ji‐Hyun Lee, S. Vadaparampil, 2015, Journal of oncology practice.

Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity.

Christopher G. King, M. V. D. van den Brink, A. Chow, 2007, Blood.

Final Report of a Phase I Trial of Decitabine with or without hyperCVAD In Relapsed Acute Lymphocytic Leukemia (ALL)

H. Kantarjian, G. Garcia-Manero, G. Borthakur, 2010 .

Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).

J. Orange, K. Bhalla, G. Garcia-Manero, 2016, Clinical lymphoma, myeloma & leukemia.

Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemia.

F. Ravandi, V. Gandhi, S. Bantia, 2013, Clinical lymphoma, myeloma & leukemia.

Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults

Martha Askins, P. Kebriaei, N. Tarek, 2014, Acta Haematologica.

Final results of a single institution experience with a pediatric‐based regimen, the augmented Berlin–Frankfurt–Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper‐CVAD regimen

M. Konopleva, H. Kantarjian, G. Garcia-Manero, 2016, American journal of hematology.

Augmented Berlin‐Frankfurt‐Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL)

M. Konopleva, H. Kantarjian, G. Garcia-Manero, 2014, Cancer.

The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma

Peng Huang, P. Zage, P. Zweidler-McKay, 2012, Investigational New Drugs.

A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

R. Advani, N. Bartlett, A. Forero-Torres, 2011, Clinical Cancer Research.

Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials

C. Bloomfield, E. Estey, R. Larson, 2013, Cancer.

Time to transplantation and pediatric acute myeloid leukemia outcomes

Amanda C. Winters, M. Verneris, L. A. Murphy, 2022, Bone Marrow Transplantation.

Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes—The MD Anderson Cancer Center experience

Diane D. Liu, L. Worth, R. Wells, 2017, Pediatric transplantation.

Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin.

Peng Huang, P. Zweidler-McKay, W. Fang, 2011, Leukemia research.

Pediatric-Based Therapy for Young Adults with Newly Diagnosed Lymphoblastic Leukemia.

H. Kantarjian, J. Cortes, T. Kadia, 2009 .

Outcome for Adolescents and Young Adults (AYA) with the Hyper-CVAD (with or without Rituximab) Regimens for De Novo Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma.

H. Kantarjian, J. Cortes, F. Ravandi, 2009 .

Long-term follow-up of patients with primary immunodeficiencies.

W. Shearer, J. Chinen, A. Franklin, 2007, The Journal of allergy and clinical immunology.

Can’t Get it Out of My Mind: A Systematic Review of Predictors of Intrusive Memories of Distressing Events

L. Zoellner, A. Franklin, Elizabeth H. Marks, 2018, Psychological bulletin.

Restlessness in Generalized Anxiety Disorder: Using Actigraphy to Measure Physiological Reactions to Threat.

A. Raine, A. M. Ruscio, A. Franklin, 2020, Behavior therapy.

Islamic Trauma Healing: Initial Feasibility and Pilot Data

Jacob A. Bentley, L. Zoellner, N. Feeny, 2018, Societies.

A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

R. Advani, N. Bartlett, A. Forero-Torres, 2011, Clinical Cancer Research.

Starting an adolescent and young adult program: some success stories and some obstacles to overcome.

A. Ferrari, B. Hayes-Lattin, M. Mascarin, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Augmented Berlin-Frankfurt-Muenster Based Therapy For Young Adults With Acute Lymphoblastic Leukemia (ALL)

H. Kantarjian, J. Cortes, F. Ravandi, 2013 .

Islamic Trauma Healing: Initial Feasibility and Pilot Data

Jacob A. Bentley, L. Zoellner, N. Feeny, 2018, Societies.